130 related articles for article (PubMed ID: 12135975)
21. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block.
Kiernan MC; Guglielmi JM; Kaji R; Murray NM; Bostock H
Brain; 2002 Mar; 125(Pt 3):664-75. PubMed ID: 11872621
[TBL] [Abstract][Full Text] [Related]
22. Membrane properties in chronic inflammatory demyelinating polyneuropathy.
Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D
Brain; 2001 Dec; 124(Pt 12):2439-47. PubMed ID: 11701598
[TBL] [Abstract][Full Text] [Related]
23. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
24. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
[TBL] [Abstract][Full Text] [Related]
25. Axonal function and activity-dependent excitability changes in myotonic dystrophy.
Krishnan AV; Kiernan MC
Muscle Nerve; 2006 May; 33(5):627-36. PubMed ID: 16453325
[TBL] [Abstract][Full Text] [Related]
26. Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease.
Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
Brain; 2006 Jun; 129(Pt 6):1585-92. PubMed ID: 16636020
[TBL] [Abstract][Full Text] [Related]
27. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
[TBL] [Abstract][Full Text] [Related]
28. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
[TBL] [Abstract][Full Text] [Related]
29. [Electrodiagnostic features in inflammatory demyelinating polyneuropathy].
Baba M; Ozaki I
Rinsho Shinkeigaku; 1995 Dec; 35(12):1365-7. PubMed ID: 8752397
[TBL] [Abstract][Full Text] [Related]
30. [Nerve conduction abnormalities in chronic inflammatory demyelinating polyneuropathy (CIDP)].
Baba M
Rinsho Shinkeigaku; 1991 Dec; 31(12):1333-6. PubMed ID: 1817802
[TBL] [Abstract][Full Text] [Related]
31. Activity-induced weakness in recessive myotonia congenita with a novel (696+1G>A) mutation.
McKay OM; Krishnan AV; Davis M; Kiernan MC
Clin Neurophysiol; 2006 Sep; 117(9):2064-8. PubMed ID: 16854622
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of myotactic reflexes in axonal and demyelinating polyneuropathy.
van Dijk GW; Wokke JH; Notermans NC; van Gijn J; Franssen H
Neurology; 1999 Oct; 53(7):1573-6. PubMed ID: 10534270
[TBL] [Abstract][Full Text] [Related]
33. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles.
Sung JY; Kuwabara S; Kaji R; Ogawara K; Mori M; Kanai K; Nodera H; Hattori T; Bostock H
Muscle Nerve; 2004 Jan; 29(1):28-37. PubMed ID: 14694495
[TBL] [Abstract][Full Text] [Related]
34. A prospective evaluation of phrenic nerve conduction in multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy.
Macia F; Le Masson G; Rouanet-Larriviere M; Habonimana D; Ferrer X; Marthan R; Lagueny A
Muscle Nerve; 2003 Sep; 28(3):319-23. PubMed ID: 12929191
[TBL] [Abstract][Full Text] [Related]
35. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome.
Cleland JC; Logigian EL; Thaisetthawatkul P; Herrmann DN
Muscle Nerve; 2003 Aug; 28(2):189-93. PubMed ID: 12872323
[TBL] [Abstract][Full Text] [Related]
36. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.
Pineda AA; Ogata K; Osoegawa M; Murai H; Shigeto H; Yoshiura T; Tobimatsu S; Kira J
J Neurol Sci; 2007 Apr; 255(1-2):1-6. PubMed ID: 17306302
[TBL] [Abstract][Full Text] [Related]
37. Different Tendencies in Muscle Ultrasound Characteristic in Amyotrophic Lateral Sclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Hokkoku K; Tsukamoto H; Uchida Y; Gatto DM; Sonoo M
J Clin Neurophysiol; 2023 Jul; 40(5):450-455. PubMed ID: 37399044
[TBL] [Abstract][Full Text] [Related]
38. Membrane property changes in most distal motor axons in chronic inflammatory demyelinating polyneuropathy.
Amino H; Shibuya K; Misawa S; Sekiguchi Y; Beppu M; Suichi T; Suzuki YI; Tsuneyama A; Kuwabara S
Muscle Nerve; 2020 Feb; 61(2):238-242. PubMed ID: 31650564
[TBL] [Abstract][Full Text] [Related]
39. [Chronic inflammatory demyelinating polyneuropathy: report of 15 cases].
Efimenko MV; Evtushenko SK; Efimenko VN
Lik Sprava; 2005; (1-2):62-5. PubMed ID: 15915996
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological and neuromuscular stability of persons with chronic inflammatory demyelinating polyneuropathy.
Gilmore KJ; Allen MD; Doherty TJ; Kimpinski K; Rice CL
Muscle Nerve; 2017 Sep; 56(3):413-420. PubMed ID: 27997686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
